| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |